This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Housing for Recovery Initiative

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05341830
Recruitment Status : Not yet recruiting
First Posted : April 22, 2022
Last Update Posted : April 22, 2022
Sponsor:
Collaborators:
Ohio Recovery Housing
Ohio State University
Information provided by (Responsible Party):
Adrienne Sabety, University of Notre Dame

Brief Summary:

Recovery housing is a substance-free group home for those exiting drug and alcohol treatment. Individuals live in a recovery-focused environment with others traveling the same journey. Ohio Recovery Housing (ORH) creates and maintains standards of excellence for recovery housing in the state. Each house decides how it operates, with four different "levels" of housing available. These environments have the potential to help build a strong foundation in recovery to improve health, employment, and housing outcomes.

ORH and LEO will launch a quasi-experimental study to measure the impact of recovery housing for individuals with substance use disorders. The design relies on variation in the availability of program spots to identify effects. Invitations to join a home will come from a waitlist. As the length of the waitlist is unrelated to applicant characteristics, movement off the waitlist can be considered essentially random. The research team will compare those who receive services to those who do not.

The researchers hypothesize that those who participate in recovery housing will have improved health, employment, and housing outcomes compared to individuals who do not receive recovery housing services.


Condition or disease Intervention/treatment Phase
Substance-related Disorders Alcohol-related Disorders Housing Behavioral: Recovery housing Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 2430 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Study participants will be added to one of two arms, treatment (recovery housing) or control (no recovery housing), through a structured waitlist. If a placement in recovery housing becomes available for an individual within two weeks of when they are placed on the waitlist for housing, they will be in the treatment group. If a placement does not become available for an individual within two weeks of when they are added to the waitlist, they will be in the control group.
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: The Effect of Recovery Housing on Patients' Health, Housing, and Employment Outcomes
Estimated Study Start Date : April 18, 2022
Estimated Primary Completion Date : March 31, 2026
Estimated Study Completion Date : March 31, 2026

Arm Intervention/treatment
Experimental: Recovery Housing
Individuals in this arm will have access to a placement in recovery housing and the associated services. Recovery housing organizations provide individuals recovering from substance use disorders with housing and a variety of services, including transportation, rental assistance, life skills, family services, and educational and employment opportunities.
Behavioral: Recovery housing
Recovery housing provides housing and other services to individuals who are recovering from substance-use disorders. They provide a substance-free living environment, as well as services to assist residents with life in recovery. These services include connections to employment and educational opportunities, help obtaining documentation such as a driver's license, connection to mutual aid, and assistance building life skills.

No Intervention: No Recovery Housing
Individuals in this arm will not receive a placement in recovery housing. When possible, they will be informed about other available services in their community.



Primary Outcome Measures :
  1. Difference in maintenance of sobriety between treatment and control groups [ Time Frame: 12 months after study enrollment ]
    Using survey data, we will quantify the effect of recovery housing participation on maintaining sobriety past 30 days and 6 months after the treatment group leaves housing. We will also measure the types of substances used (for example, alcohol, opioids,


Secondary Outcome Measures :
  1. Differences in measures of personal relationships between treatment and control groups [ Time Frame: 12 months after study enrollment ]
    We will use survey data to measure personal relationship outcomes, such as marital/cohabitation status and whether individuals have children in the custody of child welfare.

  2. Differences in measured health and social insurance coverage between treatment and control groups [ Time Frame: Up to 30 months after study enrollment ]
    We will use survey data to measure whether individuals have health insurance coverage other than Medicaid and whether they are enrolled in SNAP or TANF. We will use administrative data from the state of Ohio to measure Medicaid, SNAP, and TANF utilization.

  3. Differences in criminal justice system involvement between treatment and control groups [ Time Frame: Up to 30 months after study enrollment ]
    We will measure criminal justice outcomes by linking to publicly available criminal records, like county jail and state prison bookings records, as well as through survey data.

  4. Differences in measures of housing stability between treatment and control groups [ Time Frame: Up to 30 months after study enrollment ]
    We will use survey data to measure individuals' living arrangements (for example, in a house or apartment owned or leased in their own name, in a shared home or apartment, etc.) We will also ask retrospective questions about how many address changes they have had since exiting the waitlist. We will also measure housing stability with administrative data from Notre Dame's Infutor database.

  5. Difference in measured health care access and utilization between treatment and control groups [ Time Frame: Up to 30 months after study enrollment ]
    Using survey data, we will measure whether the respondent has a primary care provider, number of doctors' office visits, number of emergency department visits, number of prescription drug fills, and number of inpatient hospital stays in the previous six months. We will also survey individuals' self-reported physical and mental health status as well as a PHQ-2 screener for depression. We will also measure number of doctors' office visits, number of emergency department visits, number of prescription drug fills, and number of inpatient hospital stays in the previous six months using Ohio Medicaid data. We will use the Master Death Index to measure mortality.

  6. Difference in measurement of employment and financial well-being between treatment and control groups [ Time Frame: Up to 30 months after study enrollment ]
    We will use survey data to measure whether the individual has been employed over the last quarter, quarterly labor earnings, usual hours worked per week, and weeks worked over the past quarter. We also plan to use administrative data from the Ohio Department of Job and Family Services to collect data on whether the individual was employed in the last quarter and quarterly earnings. We will collect data on credit scores and use of credit from Experian.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Individuals must have a history of, or a current problem with, substance abuse
  • Individuals must be interested in starting or maintaining a lifestyle in which they do not use illicit drugs or drink alcohol
  • Individuals must understand that recovery housing programs do not provide psychiatric services
  • Individuals must be in recovery and prepared to live in a recovery housing environment

Exclusion Criteria:

  • Individuals who are under the age of 18
  • Individuals who do not consent to study participation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05341830


Contacts
Layout table for location contacts
Contact: Adrienne Sabety, PhD 574-631-6208 asabety@nd.edu
Contact: Eileen Mostyn, BA 574-631-1665 emostyn@nd.edu

Sponsors and Collaborators
Adrienne Sabety
Ohio Recovery Housing
Ohio State University
Investigators
Layout table for investigator information
Principal Investigator: Adrienne Sabety, PhD University of Notre Dame
Principal Investigator: Mary Kate Batistich, PhD University of Notre Dame
Principal Investigator: William Evans, PhD University of Notre Dame
Principal Investigator: Thomas Gregoire, PhD Ohio State University
Principal Investigator: Danielle Gray, MPH Ohio Recovery Housing
Layout table for additonal information
Responsible Party: Adrienne Sabety, Wilson Family LEO Assistant Professor of Economics, University of Notre Dame
ClinicalTrials.gov Identifier: NCT05341830    
Other Study ID Numbers: 21-09-6787
First Posted: April 22, 2022    Key Record Dates
Last Update Posted: April 22, 2022
Last Verified: April 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Alcohol-Related Disorders
Chemically-Induced Disorders
Mental Disorders